S. D’Emidio

Most-cited papers

1. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.

   G. Perrone, P. Ruffini, V. Catalano, C. Spino +15 more

   2008European Journal of Cancer204 citations

   Semantic Scholar

   Save

2. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

   V. Catalano, F. Loupakis, F. Graziano, U. Torresi +12 more

   2009British Journal of Cancer199 citations Open access

   Semantic Scholar

   Save

3. Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer.

   F. Graziano, N. Galluccio, P. Lorenzini, A. Ruzzo +13 more

   2011Journal of Clinical Oncology172 citations

   Semantic Scholar

   Save

4. Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan

   F. Graziano, E. Canestrari, F. Loupakis, A. Ruzzo +13 more

   2010The Pharmacogenomics Journal131 citations Open access

   Semantic Scholar

   Save

5. Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

   V. Catalano, F. Graziano, D. Santini, S. D’Emidio +8 more

   2008British Journal of Cancer108 citations Open access

   Semantic Scholar

   Save

6. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

   V. Catalano, F. Loupakis, F. Graziano, R. Bisonni +16 more

   2012Annals of Oncology95 citations Open access

   Semantic Scholar

   Save

7. A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases

   V. Catalano, R. Bisonni, F. Graziano, P. Giordani +8 more

   2013Gastric Cancer43 citations Open access

   Semantic Scholar

   Save

8. HtrA1, a potential predictor of response to cisplatin‐based combination chemotherapy in gastric cancer

   V. Catalano, P. Mellone, Alfredo d'Avino, V. Shridhar +14 more

   2011Histopathology26 citations

   Semantic Scholar

   Save

9. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

   V. Catalano, F. Loupakis, F. Graziano, R. Bisonni +16 more

   201220 citations Open access

   Semantic Scholar

   Save

10. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.

    F. Graziano, A. Ruzzo, E. Canestrari, V. Catalano +15 more

    2010Pharmacogenomics (London)6 citations

    Semantic Scholar

    Save

11. Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

    V. Catalano, B. Vincenzi, P. Giordani, F. Graziano +10 more

    2012Gastric Cancer2 citations Open access

    Semantic Scholar

    Save

12. Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR.

    E. Canestrari, A. Ruzzo, B. Vincenzi, N. Galluccio +16 more

    2011Journal of Clinical Oncology2 citations

    Semantic Scholar

    Save

13. Impact of mucinous histology on prognosis for patients with radically resected stage Dukes B2 and C colon cancer: Preliminary results.

    V. Catalano, F. Loupakis, R. Bisonni, U. Torresi +7 more

    2009Journal of Clinical Oncology2 citations

    Semantic Scholar

    Save

14. C-MET gene copy number variation (CNV) analysis by quantitative PCR (qPCR) assay in Caucasian patients with gastric cancer (GC).

    N. Galluccio, A. Ruzzo, Emanuele Canestrari, P. Lorenzini +10 more

    2011Journal of Clinical Oncology1 citations

    Semantic Scholar

    Save